Source link : https://newshealth.biz/health-news/oral-drug-highly-active-in-rare-blood-cancers-with-fgfr1-rearrangements/
(MedPage Today) — Most patients with myeloid/lymphoid neoplasms with FGFR1 rearrangements receiving pemigatinib (Pemazyre) experienced complete responses in the phase II FIGHT-203 trial. Among 45 patients analyzed for efficacy, the overall complete… Source link : https://www.medpagetoday.com/hematologyoncology/hematology/117168 Author : Publish date : 2025-08-26 21:15:00 Copyright for syndicated content belongs to the linked Source.
The post Oral Drug Highly Active in Rare Blood Cancers With FGFR1 Rearrangements first appeared on News Health.
—-
Author : News Health
Publish date : 2025-08-26 21:15:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8